Micardis® / MicardisPlus® Monitoring of Morning Hypertension and Metabolism II
Micardis® / MicardisPlus® Monitoring of Morning Hypertension and Metabolism II
The primary objective was to evaluate the effect of the treatment with Micardis® or MicardisPlus® on blood pressure. Secondary objectives were the effect of Micardis® / MicardisPlus® on metabolic parameters (triglycerides, cholesterol, LDL blood glucose, insulin Homeostasis Model Assessment (HOMA)-index and HbA1c) in patients with essential hypertension and diabetes mellitus
Inclusion Criteria:
Exclusion Criteria: